Standout Papers
- Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials (2023)
- Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis (2023)
Immediate Impact
21 standout
Citing Papers
Chronic Stress and Headaches: The Role of the HPA Axis and Autonomic Nervous System
2025 Standout
Global, regional, and national burden and trends of migraine among women of childbearing age from 1990 to 2021: insights from the Global Burden of Disease Study 2021
2024 Standout
Works of Faraidoon Haghdoost being referenced
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
2023 Standout
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis
2023
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Faraidoon Haghdoost | 353 | 195 | 96 | 25 | 454 | |
| Tessa de Vries | 291 | 145 | 90 | 19 | 416 | |
| C. Hedman | 290 | 166 | 147 | 21 | 414 | |
| Vincenzo Centonze | 334 | 177 | 165 | 29 | 473 | |
| Fahimeh Martami | 272 | 104 | 96 | 21 | 383 | |
| L. Hasselmark | 195 | 105 | 162 | 14 | 392 | |
| X. Michelle Androulakis | 297 | 134 | 57 | 25 | 487 | |
| Abbas Ghorbani | 239 | 154 | 78 | 22 | 429 | |
| Michele Feleppa | 319 | 141 | 135 | 17 | 484 | |
| Heikki Hakkarainen | 312 | 98 | 114 | 25 | 510 | |
| V. Pizza | 163 | 74 | 108 | 18 | 382 |
All Works
Login with ORCID to disown or claim papers
Loading papers...